Compare CDMOs manufacturing oral solid dosage forms -- tablets, capsules, and modified-release products. Filter by batch size, coating technology, and regulatory approvals.
Oral solid dose (OSD) is the most common pharmaceutical dosage form, accounting for approximately 60% of all drug products. Manufacturing involves blending, granulation (wet or dry), compression or encapsulation, film coating, and packaging. CDMOs range from small clinical-batch operations to high-throughput commercial manufacturers producing millions of units daily.
Modified-release technologies differentiate advanced OSD CDMOs. Extended-release, delayed-release, and pulsatile-release formulations improve patient compliance and can extend product lifecycle. Technologies include matrix tablets, osmotic systems, multiparticulate systems (coated pellets in capsules), and multi-layer tablets for combination products.
Scale is a key selection criterion. Clinical-phase OSD often runs in batches of 5,000-50,000 units. Commercial scale may mean 500,000+ units per batch. Equipment compatibility (granulators, presses, coaters) must match your projected volumes. Ask about batch success rates and changeover times between products.
No companies found in this category yet. Check back soon.
Browse all CDMOsOur AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.